These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8101763

  • 1. Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer.
    LeJeune S, Leek R, Horak E, Plowman G, Greenall M, Harris AL.
    Cancer Res; 1993 Aug 01; 53(15):3597-602. PubMed ID: 8101763
    [Abstract] [Full Text] [Related]

  • 2. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
    Horak E, Smith K, Bromley L, LeJeune S, Greenall M, Lane D, Harris AL.
    Oncogene; 1991 Dec 01; 6(12):2277-84. PubMed ID: 1685017
    [Abstract] [Full Text] [Related]

  • 3. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
    Berquin IM, Dziubinski ML, Nolan GP, Ethier SP.
    Oncogene; 2001 Jul 05; 20(30):4019-28. PubMed ID: 11494130
    [Abstract] [Full Text] [Related]

  • 4. Altered gene expression in drug-resistant human breast cancer cells.
    Wosikowski K, Schuurhuis D, Kops GJ, Saceda M, Bates SE.
    Clin Cancer Res; 1997 Dec 05; 3(12 Pt 1):2405-14. PubMed ID: 9815641
    [Abstract] [Full Text] [Related]

  • 5. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.
    Saeki T, Salomon DS, Johnson GR, Gullick WJ, Mandai K, Yamagami K, Moriwaki S, Tanada M, Takashima S, Tahara E.
    Jpn J Clin Oncol; 1995 Dec 05; 25(6):240-9. PubMed ID: 8523820
    [Abstract] [Full Text] [Related]

  • 6. High expression of the EGFR in fibroadenomas compared to breast carcinomas.
    Zelada-Hedman M, Werer G, Collins P, Bäckdahl M, Perez I, Franco S, Jimenez J, Cruz J, Torroella M, Nordenskjöld M.
    Anticancer Res; 1994 Dec 05; 14(5A):1679-88. PubMed ID: 7847801
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S, Takekoshi S, Suzuki Y, Saitoh Y, Tokuda Y, Osamura RY.
    Oncol Rep; 2005 Aug 05; 14(2):337-43. PubMed ID: 16012712
    [Abstract] [Full Text] [Related]

  • 8. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Aug 05; 17(2B):1417-23. PubMed ID: 9137508
    [Abstract] [Full Text] [Related]

  • 9. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.
    Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ, Crowe JP, Choueiri TK, Dawson AE, Budd GT, Tubbs RR, Casey G, Weil RJ.
    Am J Surg Pathol; 2006 Sep 05; 30(9):1097-104. PubMed ID: 16931954
    [Abstract] [Full Text] [Related]

  • 10. Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues.
    Yamamoto T, Fujita I, Akisue T, Marui T, Nakatani T, Kawamoto T, Hitora T, Nagira K, Matsumoto K, Kurosaka M.
    Anticancer Res; 2004 Sep 05; 24(2C):1307-10. PubMed ID: 15154665
    [Abstract] [Full Text] [Related]

  • 11. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers.
    Srinivasan R, Gillett CE, Barnes DM, Gullick WJ.
    Cancer Res; 2000 Mar 15; 60(6):1483-7. PubMed ID: 10749108
    [Abstract] [Full Text] [Related]

  • 12. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Mar 15; 17(4B):3091-7. PubMed ID: 9329609
    [Abstract] [Full Text] [Related]

  • 13. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.
    J Natl Cancer Inst; 2005 Sep 07; 97(17):1254-61. PubMed ID: 16145046
    [Abstract] [Full Text] [Related]

  • 14. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 15. Quantitation of the mRNA expression of the epidermal growth factor system: selective induction of heparin-binding epidermal growth factor-like growth factor and amphiregulin expression by growth factor stimulation of prostate stromal cells.
    Sørensen BS, Tørring N, Bor MV, Nexo E.
    J Lab Clin Med; 2000 Sep 15; 136(3):209-17. PubMed ID: 10985499
    [Abstract] [Full Text] [Related]

  • 16. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.
    Zajchowski D, Band V, Pauzie N, Tager A, Stampfer M, Sager R.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7041-7. PubMed ID: 3191480
    [Abstract] [Full Text] [Related]

  • 17. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma.
    Akutsu N, Bastien Y, Lin R, Mader S, White JH.
    Biochem Biophys Res Commun; 2001 Mar 09; 281(4):1051-6. PubMed ID: 11237771
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L, Jirström K, Bendahl PO, Fernö M, Nordenskjöld B, Stål O, Thorstenson S, Jönsson PE, Landberg G.
    J Clin Oncol; 2005 Jul 20; 23(21):4695-704. PubMed ID: 16034044
    [Abstract] [Full Text] [Related]

  • 20. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL.
    Cancer; 2003 Apr 15; 97(8):1841-8. PubMed ID: 12673709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.